Additional studies are needed to further validate the tumorigenic potential of OVCAR-3/CD157 and OV-90/CD157 cells in animal models; however, the in vitro data demonstrate that high expression of CD157 is sufficient to increase tumor aggressiveness and tumorigenicity in several epithelial ovarian cancer cell lines. The gene discussed is BST1; the disease is ovarian carcinoma.